Australia - English - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - hydromorphone hydrochloride, quantity: 10 mg - injection, solution - excipient ingredients: sodium citrate; water for injections; sodium chloride; citric acid monohydrate - for the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated, or are otherwise inappropriate to provide sufficient management of pain.

Australia - English - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - neostigmine methylsulfate, quantity: 2.5 mg - injection, solution - excipient ingredients: water for injections; sodium chloride - neostigmine is indicated for:,? reversal of the effects of non-depolarising neuromuscular blocking agents.,? prophylaxis and treatment of post-operative intestinal atony and urinary retention.,? treatment of myasthenia gravis during acute exacerbations, when the condition is severe or in neonates.

Australia - English - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - metaraminol tartrate, quantity: 4.744 mg (equivalent: metaraminol, qty 2.5 mg) - injection, solution - excipient ingredients: sodium chloride; water for injections; dilute hydrochloric acid - prevention and treatment of the acute hypotensive state occurring with spinal anaesthesia,adjunctive treatment of hypotension due to haemorrhage, reactions to medications, surgical complications, and shock associated with brain damage due to tumour or trauma. ,it may also be useful as an adjunct in the treatment of hypotension due to cardiogenic shock or septicaemia.

Australia - English - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - metaraminol tartrate, quantity: 9.488 mg (equivalent: metaraminol, qty 5 mg) - injection, solution - excipient ingredients: water for injections; dilute hydrochloric acid; sodium chloride - prevention and treatment of the acute hypotensive state occurring with spinal anaesthesia,adjunctive treatment of hypotension due to haemorrhage, reactions to medications, surgical complications, and shock associated with brain damage due to tumour or trauma. ,it may also be useful as an adjunct in the treatment of hypotension due to cardiogenic shock or septicaemia.

Australia - English - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - potassium chloride, quantity: 150 mg/ml - injection, concentrated - excipient ingredients: hydrochloric acid; water for injections - indications as at 04 november 2004 : 1.the treatment hypokalaemia. 2. treatment of digitalis intoxication. the iv route is indicated when the patient is unable to take potassium orally or if hypokalaemia is severe.

Australia - English - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - potassium chloride, quantity: 200 mg/ml - injection, concentrated - excipient ingredients: hydrochloric acid; water for injections - indications as at 04 november 2004 : 1.the treatment hypokalaemia. 2. treatment of digitalis intoxication. the iv route is indicated when the patient is unable to take potassium orally or if hypokalaemia is severe.

Australia - English - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - potassium chloride, quantity: 100 mg/ml - injection, concentrated - excipient ingredients: hydrochloric acid; water for injections - indications as at 04 november 2004 : 1.the treatment hypokalaemia.2. treatment of digitalis intoxication. the iv route is indicated when the patient is unable to take potassium orally or if hypokalaemia is severe.

Australia - English - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - potassium chloride, quantity: 75 mg/ml - injection, concentrated - excipient ingredients: water for injections - indications as at 04 november 2004 : 1.the treatment hypokalaemia. 2. treatment of digitalis intoxication. the iv route is indicated when the patient is unable to take potassium orally or if hypokalaemia is severe.

Australia - English - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - fentanyl citrate, quantity: 785 microgram (equivalent: fentanyl, qty 500 microgram) - injection, solution - excipient ingredients: sodium chloride; water for injections; sodium hydroxide - indications as at 31 july 2003: short duration analgesia during pre-medication, induction and maintenance of anaesthesia, and in the immediate post operative period. opioid analgesic supplement to general and regional anaesthesia. combination with a neuroleptic as an anaesthetic pre medication for the induction of anaesthesia, and as an adjunct in the maintenance of general and regional anaesthesia.

Australia - English - Department of Health (Therapeutic Goods Administration)

juno pharmaceuticals pty ltd - fentanyl citrate, quantity: 157 microgram (equivalent: fentanyl, qty 100 microgram) - injection, solution - excipient ingredients: water for injections; sodium hydroxide; sodium chloride - indications as at 31 july 2003: short duration analgesia during pre-medication, induction and maintenance of anaesthesia, and in the immediate post operative period. opioid analgesic supplement to general and regional anaesthesia. combination with a neuroleptic as an anaesthetic pre medication for the induction of anaesthesia, and as an adjunct in the maintenance of general and regional anaesthesia.